Pipeline
The Science
About us
Investors

Hit enter to search or ESC to close

Annual General Meeting Presentation 2017

November 17, 2017August 16, 2022 Alterity Therapeutics

AGM Presentation 2017

2017

Post navigation

Prana AGM Investor Conference Call

Prana receives $3 million R&D Tax Incentive Refund

Related Posts

Prana Announces RD Refund

July 17, 2013August 16, 2022

Dr David Stamler Biotech Showcase Presentation

January 8, 2018August 16, 2022

Prana Biotechnology Investor Presentation and Audio Recording – Phase 2 HD trial

February 18, 2014August 16, 2022

Recent Posts

Alterity Therapeutics Completes Last Patient Visit in ATH434-201 Phase 2 Clinical Trial in Early-Stage Multiple System Atrophy
Chairman’s Address 2024 Annual General Meeting
AGM 2024 Presentation
Alterity Therapeutics Announces Presentation on Tracking the Progression of Multiple System Atrophy at International Symposium
Alterity Therapeutics Announces New Publication Describing Novel Mechanism of Action for ATH434

Recent Comments

Archives

Archives

Categories

ASX Announcements
Chairman's Address
Investor Announcement

Tags

2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023

About us

We exist to create an alternate future for people living with neurodegenerative diseases. An alternate, healthier life. We’re here to disrupt the trajectory the world has come to accept for people with these diseases.
Improving lives.

LinkedIn
Facebook
X

Pipeline
The Science
About us
Investors
News

Careers
Privacy Policy

Copyright © Alterity Therapeutics. ABN 37 080 699 065